342 related articles for article (PubMed ID: 33401943)
1. Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships.
Hertz DL
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):227-239. PubMed ID: 33401943
[No Abstract] [Full Text] [Related]
2. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R
Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
Jin L; Zhang Y; Yang W
Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
[TBL] [Abstract][Full Text] [Related]
4. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
[TBL] [Abstract][Full Text] [Related]
5. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.
Bandla A; Tan S; Kumarakulasinghe NB; Huang Y; Ang S; Magarajah G; Hairom Z; Lim JSJ; Wong A; Chan G; Ngoi N; Ang E; Lee YM; Chan A; Lee SC; Thakor N; Wilder-Smith E; Sundar R
Support Care Cancer; 2020 Aug; 28(8):3691-3699. PubMed ID: 31811482
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the taxanes including nab-paclitaxel.
Joerger M
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):691-702. PubMed ID: 25394848
[TBL] [Abstract][Full Text] [Related]
8. Improvement of paclitaxel-induced neuropathy by substitution of docetaxel for paclitaxel.
Rose PG; Smrekar M
Gynecol Oncol; 2003 Nov; 91(2):423-5. PubMed ID: 14599877
[TBL] [Abstract][Full Text] [Related]
9. Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.
Chua KC; Xiong C; Ho C; Mushiroda T; Jiang C; Mulkey F; Lai D; Schneider BP; Rashkin SR; Witte JS; Friedman PN; Ratain MJ; McLeod HL; Rugo HS; Shulman LN; Kubo M; Owzar K; Kroetz DL
Clin Pharmacol Ther; 2020 Sep; 108(3):625-634. PubMed ID: 32562552
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.
Krens SD; McLeod HL; Hertz DL
Pharmacogenomics; 2013 Apr; 14(5):555-74. PubMed ID: 23556452
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of taxane neuropathy.
Kudlowitz D; Muggia F
Anticancer Drugs; 2014 May; 25(5):495-501. PubMed ID: 24300917
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review.
Frederiks CN; Lam SW; Guchelaar HJ; Boven E
Cancer Treat Rev; 2015 Dec; 41(10):935-50. PubMed ID: 26585358
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Marcath LA; Kidwell KM; Vangipuram K; Gersch CL; Rae JM; Burness ML; Griggs JJ; Van Poznak C; Hayes DF; Smith EML; Henry NL; Beutler AS; Hertz DL
Br J Clin Pharmacol; 2020 May; 86(5):880-890. PubMed ID: 31823378
[TBL] [Abstract][Full Text] [Related]
14. Study Protocol for Assessing the Efficacy of Compression Therapy Using Stockings and Sleeves to Prevent Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients.
Yamanouchi K; Kuba S; Matsumoto M; Yano H; Morita M; Sakimura C; Otsubo R; Kanetaka K; Nagayasu T; Eguchi S
Acta Med Okayama; 2020 Oct; 74(5):455-459. PubMed ID: 33106704
[TBL] [Abstract][Full Text] [Related]
15. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M; Imai S; Matsumoto M; Iguma Y; Kawaguchi-Sakita N; Kotake T; Iwamitsu Y; Ntogwa M; Hiraiwa R; Nagayasu K; Saigo M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Nakagawa T; Matsubara K
Cancer Res; 2021 Apr; 81(8):2207-2219. PubMed ID: 33608316
[TBL] [Abstract][Full Text] [Related]
16. An Evaluation of the Efficacy of Compression Therapy Using Sleeves and Stockings to Prevent Docetaxel-induced Peripheral Neuropathy in Breast Cancer Patients.
Yamanouchi K; Kuba S; Matsumoto M; Yano H; Morita M; Sakimura C; Otsubo R; Hidaka M; Nagayasu T; Eguchi S
Acta Med Okayama; 2022 Dec; 76(6):689-694. PubMed ID: 36549771
[TBL] [Abstract][Full Text] [Related]
17. Current Development of Oral Taxane Formulations: A Review.
Chowdhury N; Singh M
Crit Rev Ther Drug Carrier Syst; 2020; 37(3):205-227. PubMed ID: 32749138
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
[TBL] [Abstract][Full Text] [Related]
19. Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy.
Khan Z; Jung M; Crow M; Mohindra R; Maiya V; Kaminker JS; Hackos DH; Chandler GS; McCarthy MI; Bhangale T
Genome Med; 2023 Jun; 15(1):45. PubMed ID: 37344884
[TBL] [Abstract][Full Text] [Related]
20. Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non-Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient Factors.
Ojara FW; Henrich A; Frances N; Huisinga W; Hartung N; Joerger M; Kloft C
J Pharmacol Exp Ther; 2020 Dec; 375(3):430-438. PubMed ID: 33008871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
